You are here

  • Home
  • Archive
  • Volume 10, Issue 8
  • Correction: Overcoming resistance to αPD-1 of MMR-deficient tumors with high tumor-induced neutrophils levels by combination of αCTLA-4 and αPD-1 blockers

Article Text

Article menu

See original article:

Download PDFPDF

Correction
Correction: Overcoming resistance to αPD-1 of MMR-deficient tumors with high tumor-induced neutrophils levels by combination of αCTLA-4 and αPD-1 blockers

https://doi.org/10.1136/jitc-2022-005059corr1

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    Nebot-Bral L, Hollebecque A, Yurchenko AA, et al. Overcoming resistance to αPD-1 of MMR-deficient tumors with high tumor-induced neutrophils levels by combination of αCTLA-4 and αPD-1 blockers. J ImmunoTher Cancer 2022;10:e005059. doi: 10.1136/jitc-2022-005059

    This article has been corrected since it was first published online. Patricia Kannouche has now been indicated as co-corresponding author.